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Abstract
Background: The human SH3 domain Binding Glutamic acid Rich Like 3 (SH3BGRL3) gene is highly conserved in
phylogeny and widely expressed in human tissues. However, its function is largely undetermined. The protein was
found to be overexpressed in several tumors, and recent work suggested a possible relationship with EGFR family
members.
We aimed at further highlighting on these issues and investigated SH3BGRL3 molecular interactions and its role in
cellular migration ability.
Results: We first engineered the ErbB2-overexpressing SKBR3 cells to express exogenous SH3BGRL3, as well as wild
type Myo1c or different deletion mutants. Confocal microscopy analysis indicated that SH3BGRL3 co-localized with
Myo1c and ErbB2 at plasma membranes. However, co-immunoprecipitation assays and mass spectrometry
demonstrated that SH3BGRL3 did not directly bind ErbB2, but specifically recognized Myo1c, on its IQ-bearing neck
region. Importantly, the interaction with Myo1c was Ca2+-dependent.
A role for SH3BGRL3 in cell migration was also assessed, as RNA interference of SH3BGRL3 in MDA-MB-231 cells,
used as a classical migration model, remarkably impaired the migration ability of these cells. On the other side, its
over-expression increased cell motility.
Conclusion: The results of this study provide insights for the formulation of novel hypotheses on the putative role
of SH3BGRL3 protein in the regulation of myosin-cytoskeleton dialog and in cell migration. It could be envisaged
the SH3BGRL3-Myo1c interaction as a regulation mechanism for cytoskeleton dynamics. It is well known that, at low
Ca2+ concentrations, the IQ domains of Myo1c are bound by calmodulin. Here we found that binding of Myo1c to
SH3BGRL3 requires instead the presence of Ca2+. Thus, it could be hypothesized that Myo1c conformation may be
modulated by Ca2+-driven mechanisms that involve alternative binding by calmodulin or SH3BGRL3, for the
regulation of cytoskeletal activity.
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Background
The human SH3BGRL3 gene (SH3 Domain Binding Glu-
tamate Rich Protein Like 3) (also named TIP-B1) was
cloned by two independent groups [1, 2]. It belongs to a
poorly characterized gene family, comprising three other
members: SH3BGR, selectively expressed in muscle tis-
sue [3, 4], and SH3BGRL [5] and SH3BGRL2 [6], that
display ubiquitous expression. The SH3BGRL3 gene is
also ubiquitously expressed, is well conserved in phyl-
ogeny and is found in species evolutionary distant from
human. For example, an ortholog of SH3BGRL3 gene is
expressed in zebrafish, where it is already expressed in
the early stages of embryonic development [7]. These
observations indicate a high degree of evolutionary con-
servation of the gene and suggest an important bio-
logical role for the SH3BGRL3 protein.
In humans, SH3BGRL3 maps to chromosome 1p34.3–
35 and codes for a 93 amino acids protein whose three-
dimensional structure has been resolved by X-ray crys-
tallography [8] and nuclear magnetic resonance (NMR)
[9]. SH3BGRL3 protein shows similarities with glutare-
doxins, although it lacks the canonical sequence of the
corresponding redox active sites, and thus is devoid of
enzymatic activity [1]. In addition, unlike the other pro-
teins of the family, it does not have a canonical SH3 (Src
Homology 3) binding domain. Indeed, while SH3BGR,
SH3BGRL and SH3BGRL2 proteins contain the PLPP
QIF sequence, which corresponds to the SH3 consensus
sequence PXXPQ(L/I)(Y/F), SH3BGRL3 displays only a
PPQIV sequence [1, 6].
Very little information is available on its function and
its molecular interactors. In TNF-treated fibroblasts it
was characterized as having anti-apoptotic function [10].
All other studies were carried out in tumor models. In-
creased SH3BGRL3 expression was found in several tu-
mors, such as lung adenocarcinoma [11], bladder [12]
and kidney [13] cancer. Protein level in the urine of
urothelial carcinoma patients was positively associated
with tumor high grade and invasiveness [12]. High
SH3BGRL3 expression in no muscle-invasive bladder
cancer significantly correlated with increased risk of pro-
gression [12]. The latter study also demonstrated a posi-
tive association between the amount of SH3BGRL3 gene
expression achieved in the cells from a SH3BGRL3-
transfected cell line and the migration capacity of the
cells in vitro, supporting a role for this gene in metasta-
sis formation and tumor aggressiveness. Also, a correl-
ation was found between high expression of SH3BGRL3
and tumor progression in kidney clear cell carcinoma
(KIRC) [13]; moreover, SH3BGRL3 knockdown inhibited
KIRC cells proliferation, migration and invasion in vitro,
and suppressed tumor growth and metastasis in vivo
[13]. Interestingly, the authors of this study also ob-
served that the SH3BGRL3 protein may interact with
EGFR and inhibit its degradation thus enhancing the
EGF-induced AKT signaling [13]. Likewise, an analysis
of the interactome of proteins of the EGFR family
showed that the SH3BGRL3 protein can interact with
ErbB1/EGFR and ErbB2/HER2 [14], both of which are
important players in carcinogenesis [15]. Specifically, the
SH3BGRL3 protein could bind to the intracellular por-
tion of ErbB1 at the phosphorylated Tyr891 residue, and
of ErbB2 at the phosphorylated Tyr923 and Tyr1196 res-
idues [14]. However, protein structure analysis indicated
that the SH3BGRL3 protein lacks the SH2 domain [1, 6,
8] which is required for the direct docking to phosphor-
ylated Tyr residues. This result implies that SH3BGRL3
might only indirectly interact with phosphorylated EGFR
through other adaptor proteins.
In this complex and still uncertain scenario, the aim of
this work was that of obtaining new insights into the in-
teractions and function of SH3BGRL3. We found that
the SH3BGRL3 protein interacts with the IQ-bearing
neck region of the motor protein Myo1c, and that
SH3BGRL3, Myo1c and ErbB2 co-localize at plasma
membrane, possibly in membrane ruffles. We also ob-
served that SH3BGRL3 protein levels play a role in cell
migration ability.
Results
SH3BGRL3 protein binds to myosin 1c but not ErbB2 in
SKBR3 cells
The ErbB2-positive breast cancer cell line SKBR3, a
widely used model to study ErbB2 expression, was
chosen to assess the co-localization of SH3BGRL3 and
ErbB2 proteins by confocal microscopy. For this pur-
pose, we transfected SKBR3 cells with a plasmid vector
expressing an N-terminal flagged version of the
SH3BGRL3 sequence (FLAG-SH3BGRL3). The FLAG
was necessary because available anti-SH3BGRL3 anti-
bodies displayed good sensitivity for the denaturated
protein, but showed very poor binding in the case of in
situ folded protein. Thus, we had used anti-FLAG anti-
bodies to detect SH3BGRL3 with proper sensitivity.
Staining of the transfected cells with anti-ErbB2 and
anti-FLAG mAbs showed a relevant degree of co-
localization which was mostly confined to membrane
structures (Fig. 1a).
We then investigated the SH3BGRL3-ErbB2 inter-
action by co-immunoprecipitation (Co-IP); we set up
dedicated experiments using both FLAG-SH3BGRL3
and ErbB2 as bait. However, no co-precipitation of the
two molecules could be detected (data not shown), at
variance with previous literature data [14].
In order to investigate additional proteins that could
interact with SH3BGRL3, including those potentially
capable of mediating an interaction with ErbB2, we used
the following strategy. Lysates of SKBR3 cells,
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transfected either with FLAG-SH3BGRL3 or with the
empty vector (control), were exposed to an anti-FLAG-
coupled resin and the bound proteins were subsequently
eluted and analyzed by SDS-PAGE. Three protein bands
were present in the co-immunoprecipitate of FLAG-
SH3BGRL3-transfected cells and not in those from the
control cells. (Additional File 1). Mass spectrometry ana-
lyses of the three bands identified the following proteins
as potentially capable of interacting with SH3BGRL3: i)
myosin 1c (Myo1c), which is a non-conventional mono-
meric myosin; ii) adseverin (also known as scinderin),
which is an F-actin severing protein; iii) actin (Add-
itional File 2). All these proteins have a role in the cyto-
skeleton turn-over [16–18]. In particular, Myo1c is an
interesting complex protein, which harbors several regu-
latory domains. It is a monomeric motor protein [19],
expressed in all eukaryotic cells and localized primarily
at the actin-rich cellular periphery along the plasma
membrane [20]. Myo1c seems to exert an important role
in the communication between the cell and its environ-
ment by transducing signals from cell membrane recep-
tors to the cytoskeleton [16]. Thus, we focused on the
association between SH3BGRL3 and Myo1c proteins. To
validate the interaction between SH3BGRL3 and Myo1c,
a co-immunoprecipitation analysis was carried out in
SKBR3 cells transfected with the FLAG-SH3BGRL3 con-
struct as above, except that the material eluted from the
resin was analyzed by WB using either anti Myo1c (Fig.
1b) or anti ErbB2 antibodies (Fig. 1c). As evident from
the figure, Myo1c, but not ErbB2, was present in the im-
munoprecipitates with FLAG-SH3BGRL3 antibodies,
thus validating our previous unsuccessful attempts of
Fig. 1 SH3BGRL3 colocalizes with both ErbB2 and Myo1c but interacts solely with Myo1c. (a) Upper: representative confocal image of SKBR3 cells
transfected with FLAG-SH3BGRL3 and stained with anti-FLAG and anti-ErbB2 mAbs. . Scale bar = 10 μm. Lower: co-localization levels expressed as % of
SH3BGRL3-positive pixels that are also positive (over threshold) for ErbB2 fluorescence, evaluated either on the whole FLAG-SH3BGRL3-transfected cell
(left) or on ROIs gating the plasma membrane region (right) (see Methods). (b) WB analysis with anti-Myo1c antibody of Co-IP (upper inset) and lysates
(middle inset) from transfected cells (left lane) or from cells transfected with an empty vector (right lane). The lower inset displays the lysates revealed
with an anti-FLAG antibody to verify the presence of the FLAG-SH3BGRL3 bait. (c) Co-IP of endogenous Myo1c and ErbB2 using FLAG-SH3BGRL3 (left
lane), and the empty vector as negative control (right lane). WB analysis with anti-Myo1c antibody of Co-IP and lysates (two upper insets), WB analysis
with anti-ErbB2 antibody of Co-IP and lysates (third and forth insets). The lower inset displays the lysates revealed with an anti-FLAG antibody to verify
the presence of the FLAG-SH3BGRL3 bait. (d) Upper: representative confocal image of SKBR3 cells transfected with FLAG-SH3BGRL3 and stained with
anti-FLAG, anti-Myo1c and anti-ErbB2 antibodies. Arrows point to structures with a morphology that highly resembles membrane ruffles. Scale bars =
10 μm. Lower: co-localization levels expressed as % SH3BGRL3-positive pixels that are also positive (over threshold) for Myo1c or ErbB2 fluorescence,
evaluated either on the whole FLAG-SH3BGRL3-transfected cell (first two bars from the left) or on ROIs gating the plasma membrane region (two
subsequent bars) (see Methods). To further evaluate whether the SH3BGRL3/ Myo1c co-localizing spots on plasma membranes were SH3BGRL3/ ErbB2
positive as well, the triple SH3BGRL3/Myo1c/ErbB2 co-localization levels were addressed by measuring the % of Myo1c/ErbB2 co-localizing pixels that
also contained SH3BGRL3-positive fluorescence (last bar from left) (see Methods)
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co-immunprecipitating both FLAG-SH3BGRL3 and
ErbB2 from the same cell line. Confocal microscopy ana-
lysis of the intracellular distribution of FLAG-
SH3BGRL3, Myo1c and ErbB2 in SKBR3 cells indicated
a remarkable co-localization of the three proteins, which
was primarily confined to the plasma membrane, in
structures that morphologically highly resemble mem-
brane ruffles (Fig. 1d).
SH3BGRL3 protein binds the neck region of Myo1c in a
Ca2+ dependent manner
Myo1c shares a common structure with all the other
members of the myosin superfamily. This is comprised
of three domains, namely a ‘head’ region, that hydrolyzes
ATP and interacts with actin, a ‘neck’ region, that con-
tains three IQ calmodulin-binding domains plus a post-
IQ portion [21], and a ‘tail’ region, which includes a
pleckstrin-homology domain that allows Myo1c to inter-
act with the cell membrane [22].
In order to further characterize the interaction between
SH3BGRL3 and Myo1c, we designed and expressed plas-
mid constructs coding for the wild type Myo1c (Myo1c
FULL LENGTH) and for protein deletion mutants from
which one or more domains were missing (Fig. 2a). The
following mutants were used: i) Myo1c HEAD+IQ123, a
mutant that was comprised of the gene segments encod-
ing the head region and the three IQ domains ii) Myo1c
HEAD, made by the segment encoding the head region
alone iii) Myo1c NECK+TAIL that encoded three IQ do-
mains plus the region between the IQ domains and the
tail plus the tail itself iv) Myo1c TAIL, encoding for the
tail alone. All the constructs carried an HA segment en-
coding for the HA epitope located at the C-terminus of
the expressed proteins (Fig. 2a). SKBR3 cells were co-
transfected with these constructs together with the FLAG-
SH3BGRL3 vector. Co-IP experiments were then per-
formed on the lysates from these cells with an anti-FLAG
conjugated resin using the same strategy described above.
Evidence for binding to SH3BGRL3 was obtained only in
the WB of lysates from cells transfected with constructs
containing the IQ domains (Fig. 2b). This indicates that
the SH3BGRL3 protein interacts with the neck region of
Myo1c. The same Myo1c region has been reported to
bind calmodulin (CaM), a Ca2+ binding protein [21]. Since
this binding occurs only in the absence of calcium [23],
we asked the question of whether SH3BGRL3-Myo1c in-
teractions were influenced by the absence or the presence
of Ca2+. To this end, we made a construct to express the
Fig. 2 SH3BGRL3 binds to the neck region of Myo1c in a calcium dependent manner. (a) Diagram of the wild type Myo1c domains and of the
deletion mutants used for the Co-IP experiments. (b) SKBR3 cells were co-transfected with wild type and deletion mutant Myo1c constructs, each
carrying an HA tag, and FLAG-SH3BGRL3 construct. FLAG-SH3BGRL3 and Myo1c variants were co-immunoprecipitated using anti-FLAG
conjugated resin, and Myo1c variants revealed using an anti-HA antibody. Co-IP of a lysate from SKBR3 cells not transfected with any Myo1c
construct was used as negative control. (c) Endogenous Myo1c was pulled-down using GST-SHBGRL3 fusion protein or GST alone bound to
Sepharose-Glutathione 4B, in presence of Ca2+ or EGTA and revealed with an anti-Myo1c antibody. P-IQ: Post-IQ domain; PH: pleckstrin-homology
domain; HA: HA tag
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GST-SH3BGRL3 fusion protein in bacteria. The purified
GST-SH3BGRL3 fusion protein bound to Sepharose-
Glutathione 4B was used to perform pull-down experi-
ments from lysates of SKBR3 in the presence/absence of
Ca2+ or of EGTA. As evident from Fig. 2c, GST-
SH3BGRL3-Myo1c interactions required the presence of
Ca2+.
SH3BGRL3 does not bind the IQ domains of Myo1c only
To further corroborate the notion of a direct binding of
SH3BGRL3 to IQ domain-harboring proteins, we stud-
ied the interaction of SH3BGRL3 with GAP43 (neuro-
modulin), a small protein that contains a single IQ
domain [24]. This protein was selected since, unlike the
Myo1c protein, can be obtained easily in a recombinant,
purified form in vitro.
A HA-tagged GAP43 gene was cloned and expressed
into an expression vector. SKBR3 cells were then co-
transfected with both a HA-tagged GAP43 and a FLAG-
tagged SH3BGRL3 vector (or an empty vector as nega-
tive control). After co-immunoprecipitation of the cell
lysates using an anti-FLAG coupled resin, GAP43 was
found to be consistently present in the immune-
precipitates (Fig. 3a). To assess whether there is a direct
SH3BGRL3-GAP43 interaction or else this interaction is
mediated by other proteins present within a macromol-
ecular complex in the cell lysates, a GST-GAP43 fusion
protein was expressed in bacteria. The purified GST-
GAP43 protein was then coupled to Sepharose-
Glutathione 4B and used for pull-down experiments of
purified histidine-tagged SH3BGRL3 protein in presence
of Ca2+ or of EGTA. The results demonstrated that
SH3BGRL3 is capable of binding to GAP43 directly,
and, interestingly, only in the presence of Ca2+ (Fig. 3b).
SH3BGRL3 plays a role in cellular migration ability
Myo1c is involved in several cellular functions such as
generation of cell membrane tension [25], lipid raft recyc-
ling to control cell spreading and migration [26], and G-
actin transport at the leading edge of migrating cells [27].
Based on these premises, the role of the SH3BGRL3-
Myo1c interaction in cell migration was investigated using
the MDA-MB-231 cell line, which represents a classical
model for studies of this type. To this end, SH3BGRL3
protein was first demonstrated to be present in the MDA-
MB-231 cell line as could be assessed by WB (Fig. 4a);
then, the co-localization of SH3BGRL3 with Myo1c in
plasma membrane structures was confirmed by confocal
microscopy in these cells too (Fig. 4b); third, the
SH3BGRL3-Myo1c interactions in MDA-MB-231 were
documented by co-immunoprecipitation experiments
using FLAG-SH3BGL3 transfected MDA-MB-231 cells
utilizing the same procedure described above (Fig. 4c).
Thus, MDA-MB-231 cells were used to study how
modulation of SH3BGRL3 expression affects cell migra-
tion. MDA-MB-231 cells were first transfected with either
a control siRNA or one of two different siRNAs specific
for the SH3BGRL3 sequence. Results from migration as-
says carried out using Boyden chambers indicated that
downregulation of SH3BGRL3 expression results in a sig-
nificant decrease of the migration capacity, for either
siRNA (Fig. 5a). Figure 5b displays the quantification of
the SH3BGL3 down-regulation observed for the two
siRNAs, together with a representative WB.
Fig. 3 SH3BGRL3 binds to GAP43 protein in presence of Ca2+. (a)
SKBR3 cells were co-transfected with a construct coding for HA-tagged
GAP43 and a construct coding for FLAG-SH3BGRL3 or the empty
vector. FLAG-SH3BGRL3 and GAP43 were co-immunoprecipitated
using an anti-FLAG conjugated resin and GAP43 revealed using an
anti-HA antibody. (b) Purified histidine tagged SH3BGRL3 was pulled-
down using GST-GAP43 fusion protein or GST alone bound to
Sepharose-Glutathione 4B in presence of Ca2+ or EGTA. SH3BGRL3 was
revealed using an anti-SH3BGRL3 antibody
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On the other side, to test whether over-expression of
SH3BGRL3 could increase cell migration ability, we in-
fected MDA-MB-231 cells with lentivirus particles carry-
ing the SH3BGRL3 lentiviral expression plasmid (or the
same empty vector as a control). Cell migration in Boy-
den chambers resulted to be significantly increased by
SH3BGRL3 over-expression (Fig. 5c), which was assessed
by western-blot (Fig. 5d).
Discussion
This study demonstrates that SH3BGRL3 interacts with
the motor protein Myo1c in two different cell lines
(SKBR3 and MDA-MB-231). In SKBR3 cells, these pro-
teins co-localize in plasma membrane regions resembling
membrane ruffles, where also the ErbB2 protein co-
localizes with them. Moreover, silencing of SH3BGRL3
expression resulted in a decrease of cell migration capaci-
ties of the classical cell migration model MDA-MB-231,
implying that SH3BGRL3-Myo1c interactions are crucial
for cell locomotion. Finally, it was also demonstrated that
SH3BGRL3 binds to the neck region of Myo1c, which is
composed of three IQ domains. The specificity for the IQ
domains was confirmed further by the capacity of
SH3BGRL3 to bind to another protein, namely GAP43,
Fig. 4 SH3BGRL3 and Myo1c co-localize and interact also in MDA-MB-231 cells. (a) Western blot of MDA-MB-231 and SKBR3 lysates using anti-
SH3BGRL3, anti-Myo1c and anti-GAPDH antibodies. (b) Left: two representative confocal microscopy images of FLAG-SH3BGRL3 transfected MDA-
MB-231 cells stained with anti-FLAG and anti-Myo1c antibodies. Scale bar = 10 μm. Right: co-localization levels expressed as % SH3BGRL3-positive
pixels that were also positive (over threshold) for Myo1c fluorescence, evaluated either on the whole FLAG-SH3BGRL3-transfected cell (left) or on
ROIs gating the plasma membrane region (right). (c) FLAG-SH3BGRL3 and Myo1c were co-immunoprecipitated from lysates of FLAG-SH3BGRL3
transfected MDA-MB-231 cells and revealed with anti-FLAG and anti-Myo1c antibodies. Scale bar = 10 μm
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Fig. 5 (See legend on next page.)
Di Pisa et al. BMC Molecular and Cell Biology           (2021) 22:41 Page 7 of 12
which harbors a single IQ domain. The finding that
SH3BGRL3 binds with the same modality to another IQ
domain-bearing protein with a functional role different
from that of Myo1c, suggests that SH3BGRL3 may inter-
act with several proteins with IQ domains and serve differ-
ent cellular functions. SH3BGRL3 was able to bind to the
IQ domains of Myo1c - as well as to that of GAP43 - only
in presence of Ca2+, whereas calcium chelators (e.g.
EGTA) hindered the binding, possibly suggesting that
Ca2+ levels exert a regulatory function on Myo1c. At low
Ca2+ concentrations, the IQ domains of Myo1c are bound
by calmodulin and calmodulin-like proteins (CaMs) [21].
This binding increases the stability of the Myo1c ‘neck re-
gion’, which is crucial for transducing the tension gener-
ated by the motor domain to the ‘tail region’. When the
cellular Ca2+ concentration rises, CaMs dissociate from
the IQ domains and the Myo1c ‘neck region’ becomes
more flexible [21]. In this form, Myo1c is likely to become
capable of being bound by SH3BGRL3. Therefore, it could
be hypothesized that the conformation and the stiffness of
the Myo1c ‘neck region’ may be modulated by Ca2+-driven
mechanisms that cause the alternative binding of Myo1c
by either calmodulin or SH3BGRL3. This may represent a
mode of regulating cytoskeletal activity, which deserves
further experimental testing.
Recently it was shown in urothelial carcinoma cells
that SH3BGRL3 can only indirectly interact with EGFR
following stimulation of the cells with EGF for 10–30
min and that this interaction occurs through Grb2 [12].
This observation may explain why, in our experimental
setting, SH3BGRL3 and ErbB2 could not be co-
immunoprecipitated and why a direct binding of
SH3BGRL3 (that indeed does not harbor an SH2 do-
main) to ErbB2 was not detected. The interaction be-
tween Grb2 and SH3BGRL3 was suggested to occur
through the SH3BGRL3 proline-rich motif [12]. How-
ever, SH3BGRL3 does not have a canonical SH3-binding
domain [6], which is required for binding to the SH3 do-
main on Grb2 [28], leaving open the question of how
these two proteins interact. Based on these consider-
ations, literature data, and our own findings, it could be
envisaged that Myo1c may transfer the signal triggered
by ErbB2 to the actin cytoskeleton by means of a protein
complex that includes Grb2 and SH3BGRL3 as two of
multiple ‘adaptor proteins’.
A better understanding of the modulation role of
SH3BGRL3, and particularly of the mutual relationship
of this protein with ErbB2, is pivotal, given that ErbB2 is
known to regulate critical cellular processes, including
cell migration [29]. Indeed, Myo1c was recently found to
be critical for cell migration in glioblastoma and endo-
thelial cells. The migratory capacities of the malignant
cells can also dictate their mode of spreading [27, 30].
Herein, we present evidence that SH3BGRL3 may be
crucial for cell migration ability, since a substantially de-
creased migration capacity of MDA-MB-231 cells was
observed following down-regulation of SH3BGRL3. Con-
versely, over-expression of SH3BGRL3 was found to en-
hance the migration capacity of MDA-MB-231 cells, as
also observed in other cells, such as urothelial [12] and
kidney [13] carcinoma cells. Altogether, these results
provide insights for the formulation of novel hypotheses
on the putative role of SH3BGRL3 protein in cell migra-
tion and regulation of myosin-cytoskeleton dialog.
We are aware that our data indicate that SH3BGRL3
is involved in cell migration, but do not directly demon-
strate a role for the SH3BGRL3-Myo1c protein complex.
Nevertheless, given that SH3BGRL3 and Myo1c mainly
interact at plasma membrane structures recalling protru-
sions and pseudopodia involved in cellular movements,
we may reason that the interaction between SH3BGRL3
and Myo1c plays a role in cellular migration.
The two cell lines used in the present study are breast
cancer cells. However, this is simply coincidental. To ex-
plore the putative interaction of SH3BGRL3 with ErbB2,
we chose SKBR3 cells because of their high ErbB2 ex-
pression. To analyze the effects of SH3BGRL3 modula-
tion on cell motility we chose MDA-MB-231 cells
because they are a well-known model in vitro cell migra-
tion. Nevertheless, it is of note that SH3BGRL3 might be
relevant in this type of tumor, according to data from
the Human Protein Atlas that show a very high
(See figure on previous page.)
Fig. 5 Modulation of SH3BGRL3 expression impacts on the migration features of MDA-MB-231 cells. (a) Upper: Representative microscopic
images of Boyden chamber fields of migrated MDA-MB-231 cells transfected with control scrambled siRNA (CTR) or with SH3BGRL3 specific
siRNAs (siRNA #1 or siRNA #2). Lower: Quantification of the migration ability of the same cells as above. Three independent migration
experiments were carried out, in duplicate or triplicate. Each chamber slide was divided in nine fields and cell counts/field reported in the graph.
For each chamber slide of the scramble controls, the median cell counts/field was set to 100, and data of SH3BGRL3 siRNAs were normalized to
their respective scramble control. Field counts for all experiments are gathered in this graph, mean ± SD are reported and unpaired t-test was
used for evaluating statistical difference significance. (b) Western blots showing the silencing efficiency of the two SH3BGRL3 specific siRNAs.
Below are the SH3BGRL3/GAPDH ratios, normalized to the scramble control ratio, which was set to 100. c) Upper: Representative microscopic
images of Boyden chamber fields of migrated MDA-MB-231 cells subjected to lentiviral infection of either control (CTR) or SH3BGRL3 vectors.
Lower: Quantification of the migration ability of the same cells as above in two independent migration experiments, each carried out in
duplicate. Cell counts and statistical analysis were performed as detailed in a). (d) Western blots showing the efficiency of the over-expression
system. Below are the SH3BGRL3/GAPDH ratios, normalized to the control ratio, which was set to 100
Di Pisa et al. BMC Molecular and Cell Biology           (2021) 22:41 Page 8 of 12




We documented by this study that the SH3BGRL3 pro-
tein interacts with the IQ-bearing neck region of the
motor protein Myo1c in the presence of Ca2+, and that
SH3BGRL3, Myo1c and ErbB2 co-localize at plasma
membrane. Down-regulated SH3BGRL3 protein levels
impair cell migration ability, which is instead increased
by protein over-expression. These results provide in-
sights for the formulation of novel hypotheses on the
putative role of SH3BGRL3 protein in the regulation of
myosin-cytoskeleton dialog and in cell migration. It
could be envisaged the SH3BGRL3-Myo1c interaction as
a regulation mechanism for cytoskeleton dynamics.
Interestingly, the notion of a protein complex harboring
SH3BGRL3 and Myo1c as adaptor proteins may disclose
a novel mechanism of EGFR signaling to the cytoskel-
eton. Since the IQ domains of Myo1c are bound by cal-
modulin at low Ca2+, it could be hypothesized that
Myo1c conformation may be modulated by Ca2+-driven
mechanisms that involve alternative binding by cal-




Constructs were built using the In-Fusion Advantage
Cloning Kit (Clontech, CA). The DNA or cDNA tem-
plate was amplified using Taq Phusion© Hot Start Flex
DNA Polymerase (New England Biolabs) and specific In-
Fusion Cloning Primers designed to include 15 bp hom-
ologous to the ends of the linearized target vector. The
PCR products were inspected on agarose gel and then
purified using Exosap (Affimetryx). The recombination
of the purified PCR product with the vector was per-
formed following the manufacturer’s protocol. Vectors
used were the following: pFLAG-CMV (Sigma-Aldrich)
and pIRESpuro (Clontech) for eukaryotic expression,
pGEX-6P-1 (GE Life Sciences) and pQE-30 (Qiagen) for
bacterial expression. The screening of positive colonies
was performed using DNA amplification, positive clones
were amplified, and selected clones were sequenced.
Protein identification by mass spectrometry (MS) analysis
After SDS-PAGE, selected gel bands containing proteins
of interest were excised, in-gel alkylated with iodoaceta-
mide, and digested with trypsin as previously reported
[31]. Peptide mixtures were desalted with μZipTipC18
tips (Millipore) prior to nano-liquid chromatography
(nanoLC)-electrospray ionization (ESI)-linear ion trap
(LIT)-tandem (MS/MS) mass spectrometry (nanoLC-
ESI-LIT-MS/MS) analysis, which was performed on a
LTQ XL mass spectrometer equipped with a Proxeon
nanospray source linked to an Easy-nanoLC (Thermo Fi-
scher Scientific, USA). Peptides were separated on an
Easy C18 column (100 × 0.075 mm, 3 μm), at a flow rate
of 300 nl/min, using a gradient elution with acetonitrile
containing 0.1% formic acid in 0.1% formic acid, as
already reported [32]. Mass spectra were acquired in the
range m/z 400–2000 and data-dependent automatic MS/
MS acquisition was applied to the three most abundant
ions, enabling dynamic exclusion with repeat count 2
and exclusion duration 60 s. Mass isolation window and
collision energy for peptide fragmentations were set to
m/z 3 and 35%, respectively. Raw data from nanoLC-
ESI-LIT-MS/MS analysis were searched by MASCOT
v2.6.1 (Matrix Science, UK) against a UniProtKB reposi-
tory with H. sapiens taxonomy filter (20,359 sequences,
10/2019). The following parameters were used for pro-
tein identification: mass tolerance values of 1.8 Da and
0.8 Da for precursor and fragment ions, respectively;
trypsin as proteolytic enzyme with maximum missed-
cleavage sites of 2; Cys carbamidomethylation as fixed
modification, Met oxidation and Gln- > PyroGlu forma-
tion as variable modifications. Protein candidates with at
least 2 significantly matched peptide sequences (expect-
ation value < 0.05) with ion score > 30 were further con-
sidered for definitive protein assignment after manual
spectra visualization and verification. Information on
relative protein abundance in each band was derived
from emPAI score values [33].
Protein production in bacteria
Codon Plus Competent Cells (Agilent Technology) were
transformed with the construct of interest. Colonies
were screened for protein production and a productive
colony was grown in LB + Ampicillin. Protein expression
was induced with 0.1 mM IPTG for 3 h, at 37 °C. Bac-
teria were harvested and lysed with a sonicator (4 repeti-
tions of 10 s each), and the recombinant protein was
purified from the lysate using Sepharose-Glutathione 4B
(GE Healthcare) for GST-fusion proteins cloned into
pGEX-6P-1 vector, or Ni-NTA Agarose beads (Qiagen)
for His-tagged protein cloned into pQE30 vector. After
incubation with the resin at 4 °C, overnight, the protein
was analyzed by SDS-PAGE to evaluate the molecular
mass, and stored at 4 °C.
Cell lines, transfections and infections
SKBR3 (ATCC HTB-30), MDA-MB-231 (ATCC HTB-
26), and Lenti-Pac 293Ta (GeneCopoeia) cell lines were
grown in DMEM medium (Euroclone) containing 10%
FBS (ThermoFisher), 1% L-Glutamine (ThermoFisher)
and 1mg/mL penicillin/streptomycin (Sigma) in 5% CO2
humidified atmosphere.
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SKBR3 and MDA-MB-231 cell lines were transiently
transfected at 70–90% of confluence with the different
constructs using Lipofectamine 2000 (Thermo Fisher),
according to the manufacturer’s protocol. Cells were
washed and lysed 48 h after transfection.
SH3BGRL3 silencing in MDA-MB-231 was performed
using two specific SH3BGRL3 Silenced Select Pre-
designed siRNA (SH3BGRL3-siRNA #1 i.d. S37912, and
SH3BGRL3-siRNA #2 i.d. S37910, cat. Num. 4392420,
Thermo Fisher), while a Silenced Select Pre-designed
negative control siRNA (Negative control #2 cat. Num.
4390847, Thermo Fisher) was used as negative control.
All siRNAs were transfected using Lipofectamine 2000
(Thermo Fisher).
Overexpression of SH3BGRL3 in MDA-MB-231 cells
was obtained using the Lenti-Pac™ HIV Expression Pack-
aging kit (GeneCopoeia) following the manufacturer’s
protocol. Briefly, 293Ta lentiviral packaging cells were
transfected with pReceiver-Lv105-SH3BGRL3 vector or
pReceiver-LV105 empty vector. The viral particles ob-
tained in the supernatant were used to infect MDA-MB-
231 cells. Subsequently cells were selected with 1 μg/ml
puromycin (Gibco) to obtain a SH3BGRL3 over-
expressing stable MDA-MB-231 cell line and a MDA-
MB-231 cell line carrying the empty vector used as
control.
Cell lysis and western blotting
Cells were washed with PBS (Thermo Fisher) and lysed
with a scraper in EB buffer (20 mM Hepes, 150 mM
NaCl, 10% w/v glycerol, 1% w/v Triton X-100) or RIPA
buffer (Sigma) added with Protease Inhibitors Cocktail
(Sigma). Lysates were normalized based on the total pro-
tein amount, which was measured by the Bradford assay
(Bio-Rad). Samples were run in SDS-PAGE on Mini-
Protean TGX Precast Protein Gels (Bio-Rad) using Col-
orbust Electrophoresis Marker (Sigma-Aldrich) and
Leammli reducing buffer (Bio-Rad). After electrophoresis,
proteins were transferred on Hybond ECL Nitrocellulose
Membrane (GE Healthcare) by Western blot technique.
The primary antibodies used were: a rabbit polyclonal anti-
SH3BGRL3 (Product number: HPA030848, Sigma-
Aldrich), a rabbit anti-Myo1c (Prod. Num. HPA001768,
Sigma-Aldrich), a rabbit anti-ErbB2 (C18, sc284 Santa
Cruz), a rabbit polyclonal anti-GAPDH (Santa Cruz Bio-
tech.), a mouse monoclonal anti β-actin (A2228 Sigma-
Aldrich), a mouse monoclonal anti-FLAG (Sigma-Aldrich),
a mouse monoclonal anti-HA (Prod. Num. MMS-101P,
Covance). HRP-conjugated goat anti-mouse and anti-rabbit
(Santa Cruz Biotech.) were used as secondary antibodies.
To develop the membrane, Amersham ECL Western Blot-
ting Detection Reagent (GE Healthcare) and Amersham
Hyperfilm ECL (GE Healthcare) were used. Bands were de-
tected using an enhanced chemiluminescence system
(Alliance 6.7 WL 20M, UVITEC, Cambridge, UK) and
UV1D software (UVITEC).
Co-IP and pull-down experiments
SKBR3 and MDA-MB-231 cells were previously trans-
fected or co-transfected with the construct(s) of interest.
After 48 h, the cells were lysed as previously described,
and the corresponding proteins assayed with the Brad-
ford assay; the same amount of total proteins from
above-mentioned extracts was incubated with the anti-
FLAG M2 Affinity gel resin (Sigma), previously equili-
brated with EB buffer. The binding was performed over-
night at 4 °C, under shaking. To remove the unbound
proteins, the resin was washed 5 times with EB buffer
and centrifuged. Tagged proteins were detached using
10% w/v SDS. After Co-IP, proteins were loaded on
SDS-PAGE and detected using western blotting (WB).
For pull-down assays, GST-fusion proteins were bound
to Sepharose-Glutathione 4B (GE Healthcare). SKBR3
cells were lysed and normalized according to the total
protein amount. The same amount of proteins was incu-
bated with GST-fusion protein or GST alone at 4 °C,
overnight, under shaking. The binding was performed in
EB buffer containing 1 mM CaCl2 or EB buffer contain-
ing 1 or 5 mM EGTA. To remove the unbound proteins,
resin was washed 5 times with the appropriate buffer
and centrifuged. Tagged proteins were detached using
10% w/v SDS, and proteins were loaded on SDS-PAGE
and detected by WB using specific antibodies.
Immunofluorescence and confocal microscopy
After cell transfection with pCMV-FLAG/SH3BGRL3 con-
struct or pCMV-FLAG empty vector, SKBR3 and MDA-
MB-231 cells were seeded on glasses for microscopy and
fixed with 3% w/v paraformaldehyde (Sigma-Aldrich)
before staining. For intracellular fluorescence, cell
permeabilization was performed using 0.1% w/v Triton X-
100 (Sigma-Aldrich). PBS (Thermo Fisher) added with 0.5%
w/v BSA (Sigma-Aldrich) was used as washing buffer, while
PBS added with 2% w/v BSA was used for saturation.
Monoclonal mouse anti-FLAG (Sigma-Aldrich), rabbit
anti-Myo1c (Prod. Num. HPA001768, Sigma-Aldrich), and
anti-ErbB2 (Herceptin, Genentech) were used as primary
antibodies, while Alexa Fluor 488 goat anti-mouse (Thermo
Fisher), Alexa Fluor 546 goat anti-rabbit (Thermo Fisher)
and Alexa Fluor 633 goat anti-human (Thermo Fisher)
were used as secondary antibodies. DAPI (Abcam) was
used for nuclear staining. Images were acquired by the SP2-
AOBS confocal microscope (Leica Microsystems). Original
unadjusted and uncorrected images acquired under identi-
cal optical conditions were analysed by ImageJ (version J
1.34f) algorithms for the evaluation of spatial co-
localization. Regions of Interest (ROIs) on FLAG-
SH3BGRL3-GFP expressing cells were used, and co-
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localization was expressed as the percentage of
SH3BGRL3-positive pixels that were also positive for
ErbB2 or Myo1c fluorescence, above a background thresh-
old that was set by the Costes’ method [34]. Around 25
cells were analysed in each of three slides, for each experi-
ment. To evaluate co-localization of all three fluores-
cences, a mask obtained by the distribution of ErbB2/
Myo1c co-localizing pixels was created and used to deter-
mine the fraction of SH3BGRL3-positive pixels that over-
lapped with mask pixels.
Migration assays
Cells were plated in 6-wells plates (Corning) in DMEM
containing 10% FBS, 1% Pen/Strep and 1% L-glutamine
(Thermo Fisher). After 24 h from plating, siRNAs were
transfected into the cells using Lipofectamine 2000
(Thermo Fisher), according to the manufacturer’s in-
structions. Forty-eight h after transfection, cells were
starved using DMEM containing 1% Pen/Strep and 1%
Glutamax without FBS. After 8–10 h of starvation,
25,000 cells were seeded in Boyden Chambers (Migra-
tion Support for 24 Well Plate with Transparent PET
Membrane 8.0 μM pore in size, Corning). After 16 h of
migration, cells were removed from the upper side of
the filter with a cotton swab, and the cells on the lower
side of the filter were stained using 1% Cristal Violet
(Sigma-Aldrich) and fixed with 5% glutaraldehyde
(Sigma-Aldrich). The lower side of the filters were
photographed with a microscope, and cells were counted
in double-blind with the aid of NIH Image software.
Statistical analysis
Statistical significance of differences was evaluated by
unpaired non parametric t-tests using the GraphPad
Prism software (GraphPad Software Inc.).
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